Free Trial

Oculis (OCSAW) Competitors

$7.08 -0.17 (-2.33%)
As of 03:39 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

OCSAW vs. ATNFW, SXTPW, DRTSW, APLMW, BCTXW, CDIOW, CELUW, CEROW, CINGW, and CLNNW

Should you be buying Oculis stock or one of its competitors? The main competitors of Oculis include 180 Life Sciences (ATNFW), 60 Degrees Pharmaceuticals (SXTPW), Alpha Tau Medical (DRTSW), Apollomics (APLMW), BriaCell Therapeutics (BCTXW), Cardio Diagnostics (CDIOW), Celularity (CELUW), CERo Therapeutics (CEROW), Cingulate (CINGW), and Clene (CLNNW). These companies are all part of the "biotechnology" industry.

Oculis vs. Its Competitors

180 Life Sciences (NASDAQ:ATNFW) and Oculis (NASDAQ:OCSAW) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, media sentiment, valuation, earnings, analyst recommendations, profitability, risk and dividends.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
180 Life SciencesN/AN/AN/AN/AN/A
OculisN/AN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
180 Life SciencesN/A N/A N/A
Oculis N/A N/A N/A

In the previous week, 180 Life Sciences' average media sentiment score of 0.00 equaled Oculis'average media sentiment score.

Company Overall Sentiment
180 Life Sciences Neutral
Oculis Neutral

Summary

180 Life Sciences and Oculis tied by winning 0 of the 0 factors compared between the two stocks.

Get Oculis News Delivered to You Automatically

Sign up to receive the latest news and ratings for OCSAW and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding OCSAW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

OCSAW vs. The Competition

MetricOculisBiotechnology IndustryMedical SectorNASDAQ Exchange
Market CapN/A$134.49M$5.45B$9.68B
Dividend YieldN/A3.74%3.99%4.14%
P/E RatioN/A3.7930.1125.01
Price / SalesN/A4,344.35379.5578.79
Price / CashN/A13.1935.9458.58
Price / BookN/A38.648.135.68
Net IncomeN/A-$90.30M$3.26B$265.68M
7 Day Performance-2.47%1.91%1.15%2.51%
1 Month Performance-10.86%4.04%2.82%1.88%
1 Year Performance197.52%180.44%28.41%24.00%

Oculis Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
OCSAW
Oculis
N/A$7.08
-2.3%
N/AN/A$0.00N/A0.0032Gap Up
ATNFW
180 Life Sciences
N/A$0.01
+0.8%
N/A-7.4%$0.00N/A0.007High Trading Volume
SXTPW
60 Degrees Pharmaceuticals
N/A$0.06
+21.5%
N/A+75.0%$0.00$665.45K0.002Gap Up
DRTSW
Alpha Tau Medical
N/A$0.23
-2.9%
N/A+7.9%$0.00N/A0.0080
APLMW
Apollomics
N/A$0.03
-7.6%
N/AN/A$0.00N/A0.0059Positive News
Gap Down
BCTXW
BriaCell Therapeutics
N/A$0.05
-2.8%
N/A-85.5%$0.00N/A0.008Negative News
Gap Up
CDIOW
Cardio Diagnostics
N/A$0.01
-1.4%
N/A-70.9%$0.00$19.90K0.007Positive News
Gap Down
CELUW
Celularity
N/A$0.05
-16.5%
N/AN/A$0.00$54.22M0.00220Positive News
Gap Down
CEROW
CERo Therapeutics
N/A$0.02
-10.6%
N/A-62.0%$0.00N/A0.008Positive News
Short Interest ↑
Gap Down
CINGW
Cingulate
N/A$0.13
+9.4%
N/A+530.0%$0.00N/A0.0020Positive News
CLNNW
Clene
N/A$0.03
-31.1%
N/A-18.8%$0.00$350K0.00100Positive News
Gap Down

Related Companies and Tools


This page (NASDAQ:OCSAW) was last updated on 8/8/2025 by MarketBeat.com Staff
From Our Partners